Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease

Neurobiol Aging. 2006 May;27(5):773.e1-773.e3. doi: 10.1016/j.neurobiolaging.2005.03.029. Epub 2005 Aug 1.

Abstract

Recent studies have provided evidence toward the possible involvement of brain cholesterol homeostasis in late-onset Alzheimer's disease (LOAD). We analyzed an intronic T-->C substitution (rs 754203) of the cholesterol 24S-hydroxylase (CYP46) gene, encoding an enzyme acting on brain cholesterol turnover, which has been recently associated with an increased risk of AD, dependent or not on Apolipoprotein E (ApoE) genotype. No significant association was found for the CYP46 polymorphism in LOAD compared to the controls, even after stratification for the presence/absence of the ApoE*4 allele. Our data do not support a role of the CYP46 polymorphism as a possible susceptibility factor for developing AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics*
  • Apolipoproteins E / genetics
  • Cholesterol 24-Hydroxylase
  • Female
  • Gene Frequency
  • Genotype
  • Heterozygote
  • Humans
  • Italy / epidemiology
  • Male
  • Polymorphism, Genetic / genetics
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Steroid Hydroxylases / genetics*

Substances

  • Apolipoproteins E
  • Steroid Hydroxylases
  • Cholesterol 24-Hydroxylase